Cardinal Health, Inc. (LON:0HTG)

London flag London · Delayed Price · Currency is GBP · Price in USD
148.07
-0.77 (-0.52%)
At close: May 12, 2025
50.97%
Market Cap 26.60B
Revenue (ttm) 172.05B
Net Income (ttm) 1.21B
Shares Out n/a
EPS (ttm) 4.94
PE Ratio 22.08
Forward PE 16.37
Dividend 1.58 (1.06%)
Ex-Dividend Date Jul 1, 2025
Volume 428
Average Volume 362
Open 148.00
Previous Close 148.84
Day's Range 143.85 - 148.07
52-Week Range 68.75 - 135.61
Beta 0.63
RSI 67.60
Earnings Date May 1, 2025

About Cardinal Health

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare... [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 1979
Employees 48,900
Stock Exchange London Stock Exchange
Ticker Symbol 0HTG
Full Company Profile

Financial Performance

In 2024, Cardinal Health's revenue was $226.83 billion, an increase of 10.66% compared to the previous year's $204.98 billion. Earnings were $852.00 million, an increase of 158.18%.

Financial numbers in USD Financial Statements

News

63 Top Dividend Growth Stocks For May 2025

I present 63 high-quality dividend growth stocks for investment for May 2025, categorized by yield: High (4%+), Medium (2.5-3.9%), and Low (

4 days ago - Seeking Alpha

Marjorie Taylor Greene Goes Stock Shopping Again: Here Are 50+ Stocks The Congresswoman Bought

Rep. Marjorie Taylor Greene (R-Ga.) has been actively buying stocks in 2025, including transactions that may have been perfectly timed during a market dip. Here's the latest transactions made by the c...

5 days ago - Benzinga

Cardinal Health releases new report on the cell and gene therapy industry

Analysis charts the emergence and future of advanced therapies DUBLIN, Ohio , May 7, 2025 /PRNewswire/ -- Today, Cardinal Health (NYSE: CAH) released its 2025 Advanced Therapies Report: Revolutionizin...

5 days ago - PRNewsWire

Cardinal Health Board of Directors Approves Quarterly Dividend

DUBLIN, Ohio , May 5, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved an increase to its quarterly dividend, to $0.5107 per share, out of the Comp...

7 days ago - PRNewsWire

Henry Schein's Reports Mixed Bag Q1 Earnings, CEO Confident In Business Fundamentals

Henry Schein Inc. (NYSE: HSIC) reported on Monday that its first-quarter adjusted EPS of $1.15, up 4.5% year over year, beat the consensus of $1.11 . Sales were $3.17 billion, missing the consensus o...

7 days ago - Benzinga

Cardinal Health, Northrop Grumman Among 7 Companies To Announce Dividend Increases In First Half Of May

Parker-Hannifin announced its latest payout boost. Check out companies that I expect will announce their annual dividend increases in the first half of May.

8 days ago - Seeking Alpha

Cardinal Health Lifts FY25 EPS Outlook, Sees Growth Despite Tariff Risks

Cardinal Health Inc. (NYSE: CAH) on Thursday reported third-quarter 2025 adjusted EPS of $2.35, up 13% year over year, beating the consensus of $2.17 . Sales remained flat at $54.9 billion, missing t...

11 days ago - Benzinga

Cardinal Health Lifts FY25 EPS Outlook, Sees Growth Despite Tariff Risks

Cardinal Health Inc. CAH on Thursday reported third-quarter 2025 adjusted EPS of $2.35, up 13% year over year, beating the consensus of $2.17.

11 days ago - Benzinga

Cardinal Health lifts full-year profit forecast again on specialty medicine sales

Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast for the fourth time, betting on strong demand for costly specialty medicines and branded drugs.

11 days ago - Reuters

Cardinal Health Reports Third Quarter Fiscal Year 2025 Results and Raises Fiscal Year 2025 Outlook

Revenue was flat at $54.9 billion; revenue increased 19% excluding the impact of the previously communicated customer contract expiration GAAP 1 operating earnings were $730 million; GAAP diluted EPS ...

11 days ago - PRNewsWire

Best Dividend Aristocrats For May 2025

Despite a strong start, the Dividend Aristocrats are underperforming the S&P 500 in April, with NOBL down 4.88% and SPY down 1.53%. The best-performing Dividend Aristocrats YTD include Consolidated Ed...

13 days ago - Seeking Alpha

Is the Market Bullish or Bearish on Cardinal Health?

Cardinal Health's (NYSE: CAH) short percent of float has fallen 29.09% since its last report. The company recently reported that it has 4.71 million shares sold short , which is 2.56% of all regular ...

21 days ago - Benzinga

ESG Still Matters. 3 Defensive Stocks That Make the Grade.

Cardinal Health, Atmos Energy, and General Mills make the cut for one ESG fund manager.

4 weeks ago - Barrons

Best Dividend Aristocrats For April 2025

Dividend Aristocrats are outperforming the S&P 500 in 2025, demonstrating resilience, with NOBL up 1.78% YTD versus SPY's 4.9% decline. Top performers include Consolidated Edison (+22.98%), Brown & Br...

6 weeks ago - Seeking Alpha

Profits at Cardinal Healths Irish unit jump to 6m despite planned closure of plant

Profits at the Tullamore-based operation of US medical device maker Cardinal Health soared 20pc last year to 6m even as it announced it will close the facility by next year with the loss of more than ...

6 weeks ago - Independent Ireland

Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2025 on May 1

DUBLIN, Ohio , March 25, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2025 on May 1, prior to the opening of trading on the New...

6 weeks ago - PRNewsWire

Cardinal Health: A Safe Bet On U.S. Healthcare But Valuations Aren't Enticing

Cardinal Health outpaces S&P 500 with strong growth in specialty pharmaceuticals. Read why CAH stock has limited upside potential.

7 weeks ago - Seeking Alpha

Cardinal Health, Inc. (CAH) Leerink's 2025 Global Healthcare Conference (Transcript)

Cardinal Health, Inc. (NYSE:CAH) Leerink's 2025 Global Healthcare Conference Call March 12, 2025 8:40 AM ET Company Participants Aaron Alt - Chief Financial Officer Matt Sims - Investor Relations Con...

2 months ago - Seeking Alpha

Robert Musslewhite and Sudhakar Ramakrishna to join Cardinal Health Board of Directors

DUBLIN, Ohio , March 10, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors has elected Robert Musslewhite, former Chief Executive Officer of Definitive Health...

2 months ago - PRNewsWire

The Dividend Aristocrats Ranked By Quality Scores: March 2025

S&P Dow Jones Indices added three new members to the S&P 500 Dividend Aristocrats Index, expanding it to 69 companies. I rank Dividend Aristocrats by quality scores, presenting undervalued and overval...

2 months ago - Seeking Alpha